Page last updated: 2024-11-05

tetraethylammonium and Cardiomegaly

tetraethylammonium has been researched along with Cardiomegaly in 2 studies

Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)

Cardiomegaly: Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walsh, KB1
Sweet, JK1
Parks, GE1
Long, KJ1
Cameron, JS1
Kimura, S1
Jackson-Burns, DA1
Smith, DB1
Bassett, AL1

Other Studies

2 other studies available for tetraethylammonium and Cardiomegaly

ArticleYear
Modulation of outward potassium currents in aligned cultures of neonatal rat ventricular myocytes during phorbol ester-induced hypertrophy.
    Journal of molecular and cellular cardiology, 2001, Volume: 33, Issue:6

    Topics: Animals; Cardiomegaly; Cells, Cultured; Delayed Rectifier Potassium Channels; Electric Conductivity;

2001
ATP-sensitive K+ channels are altered in hypertrophied ventricular myocytes.
    The American journal of physiology, 1988, Volume: 255, Issue:5 Pt 2

    Topics: 4-Aminopyridine; Adenosine Triphosphate; Aminopyridines; Animals; Calcium; Cardiomegaly; Cats; Dose-

1988